OMERACT systemic lupus erythematosus domain survey

By sjmartinez • August 7, 2024

Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, Thumboo J, Aringer M, Mosca M, Bruce I, Parodis I, Kim A, Desai M, Enman Y, Shea B, Wallace DJ, Chaichian Y, Navarra S, Aranow C, Mackay M, Trotter K, Tayer-Shifman OE, Duarte-García A, Shan Tam L, Ugarte-Gil MF, Pons-Estel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Gladman DD, Arnaud L, Bultink IEM, Ruiz-Irastorza G, Inês LS, Appenzeller S, Dobrowolski C, Clarke AE, Kamen DL, Barraclough M, Tani C, Gómez-Puerta JA, Werth VP, Katz P, Nowrouzi-Kia B, Johnson SR, Drucker AM, Touma Z; OMERACT SLE Working Group. OMERACT systemic lupus erythematosus domain survey. Semin Arthritis Rheum. 2024 Jul 24;68:152520. doi: 10.1016/j.semarthrit.2024.152520. Epub ahead of print. PMID: 39106780.

Tags: Cedars Sinai DoM, Core outcome set, Domain, Publications, Rheumatology, systemic lupus erythematosus

Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain

Hein Da Rosa T, Ramsey SH, Lee JJ, Kozlova NY, Zhao Z, Kim J, Schneider AC, Li S, Katiki M, Firestein GS, Murali R, Santelli[...]

Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases

Gamez J, Zha D, Ebrahimi SM, White S, Ljubimov AV, Saghizadeh M. Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases. Cells. 2025 Jun[...]

Leveraging A Randomized Trial to Assess Relationships between Transeptal Puncture, Brain Emboli, and Migraine Symptoms

Elias A, Tung R, Gerstenfeld EP, Hue TF, Lin F, Cheng J, Weiss JP, Tzou WS, Hsia H, Ehdaie A, Cooper DH, Bunch TJ, Arkles[...]